Treating pancreatic cancer with a combination of chemotherapy, biotherapy and radiotherapy prior to surgery is safe and may be beneficial for patients, according to a new study. In the preliminary study, physicians examined the safety of combining gemcitabine with bevacizumab and radiotherapy in patients with operable pancreatic cancer.